Familial nonmedullary thyroid cancer

Area of Science:

• Oncology
• Genetics
• Endocrinology

Background:

• Familial nonmedullary thyroid cancer (FNMTC) presents as inherited thyroid tumors of follicular cell origin.
• FNMTC is associated with increased multifocality, earlier onset, higher recurrence rates, and greater aggressiveness compared to sporadic thyroid cancers.
• While some candidate genes for rare FNMTC variants are known, the genetic basis for most cases remains unidentified.

Purpose of the Study:

• To review the characteristics, genetic underpinnings, and management of familial nonmedullary thyroid cancer.
• To emphasize the need for continued research into the genetic causes of FNMTC.
• To outline optimal clinical surveillance and treatment protocols for FNMTC patients.

Main Methods:

• Literature review of familial nonmedullary thyroid cancer studies.
• Analysis of clinical presentation, inheritance patterns, and genetic findings.
• Synthesis of current recommendations for diagnosis, treatment, and follow-up.

Main Results:

• FNMTC exhibits distinct clinical features and an autosomal dominant inheritance pattern with reduced penetrance is likely.
• The specific genes responsible for the majority of FNMTC cases are yet to be discovered.
• Effective management involves aggressive treatment, including total thyroidectomy, neck dissection, radioiodine ablation, and TSH suppressive therapy.

Conclusions:

• Identifying the genetic drivers of FNMTC is crucial for understanding its pathogenesis and developing targeted therapies.
• Longitudinal monitoring with physical exams and ultrasonography is essential for early detection and management.
• A comprehensive treatment and follow-up strategy, including surgical intervention and adjuvant therapies, is vital for improving outcomes in FNMTC patients.